Evidence map›Paper›PMID 17880691›Full record

ArticleBMC developmental biology2007

Neuregulin3 alters cell fate in the epidermis and mammary gland.

Heena Panchal, Olivia Wansbury, Suzanne Parry, Alan Ashworth, Beatrice Howard

Open access · hybridAbstract read
In one paragraph

Article in BMC developmental biology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.6field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 46 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Embryonic Mammary Gland Morphogenesis.Advances in experimental medicine and biology · 2025
    Review
  5. Article
  6. Embryonic Programs in Cancer and Metastasis-Insights From the Mammary Gland.Frontiers in cell and developmental biology · 2022
    Review
  7. Review
  8. Genetically modified laboratory mice with sebaceous glands abnormalities.Cellular and molecular life sciences : CMLS · 2016
    Review
  9. Article
  10. Article
  11. Article
  12. Stem cells and the developing mammary gland.Journal of mammary gland biology and neoplasia · 2013
    Review
  13. Ectodysplasin/NF-κB signaling in embryonic mammary gland development.Journal of mammary gland biology and neoplasia · 2013
    Review
  14. Neuregulin 3 and erbb signalling networks in embryonic mammary gland development.Journal of mammary gland biology and neoplasia · 2013
    Review
  15. Functionalized silk biomaterials for wound healing.Advanced healthcare materials · 2013
    Article
  16. Article
  17. Article
  18. Review
  19. Molecular mechanisms guiding embryonic mammary gland development.Cold Spring Harbor perspectives in biology · 2010
    Review
  20. Analysis of gene expression in PTHrP-/- mammary buds supports a role for BMP signaling and MMP2 in the initiation of ductal morphogenesis.Developmental dynamics : an official publication of the American Association of Anatomists · 2009
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Heena PanchalThe Breakthrough Breast Cancer Research Centre, Institute of Cancer Research 237 Fulham Road, London SW3 6JB, UK. heena.panchal@icr.ac.uk
Olivia Wansbury
Suzanne Parry
Alan Ashworth
Beatrice Howard
Breast Cancer Research Foundation · USInstitute of Cancer Research · GB

Funding

Breast Cancer Now BREAST CANCER NOW RESEARCH CENTRE
6 · The paper itself

Abstract

backgroundThe Neuregulin family of ligands and their receptors, the Erbb tyrosine kinases, have important roles in epidermal and mammary gland development as well as during carcinogenesis. Previously, we demonstrated that Neuregulin3 (Nrg3) is a specification signal for mammary placode formation in mice. Nrg3 is a growth factor, which binds and activates Erbb4, a receptor tyrosine kinase that regulates cell proliferation and differentiation. To understand the role of Neuregulin3 in epidermal morphogenesis, we have developed a transgenic mouse model that expresses Nrg3 throughout the basal layer (progenitor/stem cell compartment) of mouse epidermis and the outer root sheath of developing hair follicles.

resultsTransgenic females formed supernumerary nipples and mammary glands along and adjacent to the mammary line providing strong evidence that Nrg3 has a role in the initiation of mammary placodes along the body axis. In addition, alterations in morphogenesis and differentiation of other epidermal appendages were observed, including the hair follicles. The transgenic epidermis is hyperplastic with excessive sebaceous differentiation and shows striking similarities to mouse models in which c-Myc is activated in the basal layer including decreased expression levels of the adhesion receptors, alpha6-integrin and beta1-integrin.

conclusionThese results indicate that the epidermis is sensitive to Nrg3 signaling, and that this growth factor can regulate cell fate of pluripotent epidermal cell populations including that of the mammary gland. Nrg3 appears to act, in part, by inducing c-Myc, altering the proliferation and adhesion properties of the basal epidermis, and may promote exit from the stem cell compartment. The results we describe provide significant insight into how growth factors, such as Nrg3, regulate epidermal homeostasis by influencing the balance between stem cell renewal, lineage selection and differentiation.

Indexed as

AnimalsCell AdhesionCell DifferentiationCell ProliferationEpidermal CellsEpidermisFemaleIntracellular Signaling Peptides and ProteinsMaleMammary Glands, AnimalMiceMice, KnockoutMice, TransgenicNeuregulinsProto-Oncogene Proteins c-mycStem CellsIntracellular Signaling Peptides and ProteinsMyc protein, mouseNeuregulinsNrg3 protein, mouseProto-Oncogene Proteins c-myc

Identifiers

PMID17880691
PMCPMC2110892
OpenAlexW1965883204

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.